PF-04620110
| CAS No. | 1109276-89-2 | Cat. No. | BCP16812 |
| Name | PF-04620110 | ||
| Synonyms | PF04620110;PF 04620110; | ||
| Formula | C21H24N4O4 | M. Wt | 396.44 |
| Description | PF-04620110 and imipramine (internal standard) were separated using a Hypersil Gold C18 column, with a mixture of acetonitrile and 10 mm ammonium formate (90:10, v/v) as the mobile phase. The ion transitions monitored in positive-ion mode [M + H](+) of multiple-reaction monitoring were m/z 397.0 → 260.2 for PF-04620110 and m/z 280.8 → 86.0 for imipramine. The detector response was specific and linear for PF-04620110 at concentrations within the range 0.05-50 μg/mL and the signal-to-noise ratios for the samples were ≥10. | ||
| Pathways | Protease/Metabolic Enzyme | ||
| Targets | DGAT | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.